Suven Pharmaceuticals Limited (SUVENPHAR.NS) NSE
Currency In INR
- General
- Statistics
- Historical Data
- Profile
- Financials
Suven Pharmaceuticals Limited
Address
# 8-2-334, SDE Serene Chambers
Hyderabad, 500034
India
Phone
91 40 2354 9414
Website
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
1193
First IPO Date
March 09, 2020
Key Executives
| Name | Title | Pay | Year Born |
| Sudhir Kumar Singh | Chief Executive Officer | 0 | 1965 |
| Vivek Sharma | Executive Chairman | 27.27M | N/A |
| Declan Ryan | Chief Commercial Officer | 0 | N/A |
| Subba Raju Komaravolu | Chief Strategy Officer | 0 | N/A |
| Sunder Venkatraman | Vice President of Corporate Affairs | 0 | N/A |
| Cyndrella Carvalho | Head of Investor Relations | 0 | N/A |
| Vetukuri Venkata Naga Kali Vara Prasada Raju | MD & Director | 0 | N/A |
| Gaurav Narain Bahadur | Chief Human Resources Officer | 0 | 1970 |
| K. Nagendra Babu | Chief Quality & Compliance Officer | 0 | N/A |
| Himanshu Agarwal | Chief Financial Officer | 0 | 1970 |
| Kundan Kumar Jha | Company Secretary & Compliance Officer | 0 | N/A |
Description
Established in 2018 and based in Hyderabad, India, Suven Pharmaceuticals Limited functions as a global biopharmaceutical firm. The company offers comprehensive contract research and manufacturing services (CRAMS) to pharmaceutical, biotechnology, and chemical sectors worldwide, with operations spanning India, the United States, and Europe. Through these services, Suven develops, produces, and commercializes various critical substances, including intermediates derived from new chemical entities, active pharmaceutical ingredients (APIs), specialty chemicals, and finished drug formulations. It operates as a division under Jasti Property and Equity Holdings Private Limited.
